Open access
2,189
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus
Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan
Junko Terada-Hirashimaa Department of Clinical Research Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan;b Department of Respiratory Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, JapanCorrespondence[email protected]
https://orcid.org/0000-0002-1437-5896View further author information
Yuki Takamatsuc Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Shinjuku-ku, Tokyo, JapanView further author information
, Yosuke Shimizud Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanView further author information
, Yukari Uemurad Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanView further author information
, Junko S. Takeuchie Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanView further author information
, Noriko Tomitaa Department of Clinical Research Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanView further author information
, Kouki Matsudac Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Shinjuku-ku, Tokyo, JapanView further author information
, Kenji Maedac Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Shinjuku-ku, Tokyo, JapanView further author information
, Shohei Yamamotof Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanView further author information
, Ami Fukunagaf Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanView further author information
, Norio Ohmagarig Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, JapanView further author information
, Ayako Mikamia Department of Clinical Research Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanView further author information
, Kengo Sonodah Development Department, KM Biologics Co. Ltd, Kumamoto, JapanView further author information
, Mugen Ujiieg Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, JapanView further author information
, Hiroaki Mitsuyac Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Shinjuku-ku, Tokyo, JapanView further author information
& Wataru Sugiurai Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanView further author information
show all
Article: 2193074
|
Received 02 Oct 2022, Accepted 14 Mar 2023, Published online: 13 Apr 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.